In vitro and in vivo antifungal activity of lichochalcone-A against candida albicans biofilms

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Seleem, Dalia ^a   Benso, Bruna ^b   Noguti, Juliana ^a   Pardi, Vanessa ^a   Murata, Ramiro Mendonça ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LICHOCHALCONE A; UNCLASSIFIED DRUG; CHALCONE DERIVATIVE; INTERLEUKIN DERIVATIVE; LICOCHALCONE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME DEGRADATION; FUNGAL LOAD; FUNGAL VIABILITY; FUNGUS GROWTH; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM FUNGICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PATHOGEN LOAD; PROTEIN EXPRESSION; THRUSH; TREATMENT DURATION; ANIMAL; CANDIDIASIS, ORAL; CELL LINE; CHEMISTRY; COCULTURE; DRUG EFFECTS; FIBROBLAST; GLYCYRRHIZA; HUMAN; MICROBIOLOGY; MOUTH; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CELL LINE; CHALCONES; COCULTURE TECHNIQUES; FIBROBLASTS; GLYCYRRHIZA; HUMANS; INTERLEUKINS; MICE; MOUTH;

EID: 84975757511     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157188     Document Type: Article

References (45)

1. Das I, Nightingale P, Patel M, Jumaa P (2011) Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis 15: e759-763. doi: 10. 1016/j.ijid.2011.06.006 PMID: 21840742
2. Prieto D, Correia I, Pla J, Roman E (2016) Adaptation of Candida albicans to commensalism in the gut. Future Microbiol.
3. Badiee P, Hashemizadeh Z (2014) Opportunistic invasive fungal infections: diagnosis & clinical management. Indian J Med Res 139: 195-204. PMID: 24718393
4. Nanteza M, Tusiime JB, Kalyango J, Kasangaki A (2014) Association between oral candidiasis and low CD4+ count among HIV positive patients in Hoima Regional Referral Hospital. BMC Oral Health 14:143. doi: 10.1186/1472-6831-14-143 PMID: 25432363
5. Borg-von Zepelin M, Meyer I, Thomssen R, Wurzner R, Sanglard D, Telenti A., et al. (1999) HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol 113: 747-751. PMID: 10571729
6. Tang HJ, Liu WL, Lin HL, Lai CC (2014) Epidemiology and prognostic factors of candidemia in cancer patients. PLoS One 9: e99103. doi: 10.1371/journal.pone.0099103 PMID: 24901336
7. Eggimann P, Que YA, Revelly JP, Pagani JL (2015) Preventing invasive candida infections. Where could we do better? J Hosp Infect 89: 302-308. doi: 10.1016/j.jhin.2014.11.006 PMID: 25592726
8. Gillies M, Ranakusuma A, Hoffmann T, Thorning S, McGuire T, Glasziou P. et al. (2015) Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication. Cmaj 187: E21-31. doi: 10.1503/cmaj.140848 PMID: 25404399
9. Correia A, Lermann U, Teixeira L, Cerca F, Botelho S, da Costa R. M., et al. (2010) Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect Immun 78: 4839-4849. doi: 10.1128/IAI. 00248-10 PMID: 20679440
10. Tsui C, Kong EF, Jabra-Rizk MA (2016) Pathogenesis of Candida albicans Biofilm. Pathog Dis.
11. Inigo M, Peman J, Del Pozo JL (2012) Antifungal activity against Candida biofilms. Int J Artif Organs 35: 780-791. doi: 10.5301/ijao.5000170 PMID: 23138707
12. Villar CC, Kashleva H, Nobile CJ, Mitchell AP, Dongari-Bagtzoglou A (2007) Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect Immun 75: 2126-2135. PMID: 17339363
13. Naglik JR, Moyes D, Makwana J, Kanzaria P, Tsichlaki E, Weindl G, et al. (2008) Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 154: 3266-3280. doi: 10.1099/mic.0.2008/022293-0 PMID: 18957581
14. Lalla RV, Patton LL, Dongari-Bagtzoglou A (2013) Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies. J Calif Dent Assoc 41: 263-268. PMID: 23705242
15. Bilecova-Rabajdova M, Birkova A, Urban P, Gregova K, Durovcova E, Marekova M (2013) Naturally occurring substances and their role in chemo-protective effects. Cent Eur J Public Health 21: 213-219. PMID: 24592727
16. Chen Z, Zheng S, Li L, Jiang H (2014) Metabolism of flavonoids in human: a comprehensive review. Curr Drug Metab 15: 48-61. PMID: 24588554
17. Messier C, Epifano F, Genovese S, Grenier D (2012) Licorice and its potential beneficial effects in common oro-dental diseases. Oral Dis 18: 32-39. doi: 10.1111/j.1601-0825.2011.01842.x PMID: 21851508
18. Hao H, Hui W, Liu P, Lv Q, Zeng X, Jiang H, et al. (2013) Effect of licochalcone A on growth and properties of Streptococcus suis. PLoS One 8: e67728. doi: 10.1371/journal.pone.0067728 PMID: 23935843
19. Mosci P, Pericolini E, Gabrielli E, Kenno S, Perito S, Bistoni F, et al. (2013) A novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice. Virulence 4: 250-254. doi: 10.4161/ viru.23529 PMID: 23334179
20. Vande Velde G, Kucharikova S, Schrevens S, Himmelreich U, Van Dijck P (2014) Towards non-invasive monitoring of pathogen-host interactions during Candida albicans biofilm formation using in vivo bioluminescence. Cell Microbiol 16: 115-130. doi: 10.1111/cmi.12184 PMID: 23962311
21. Chryssanthou E, Cuenca-Estrella M (2002) Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. J Clin Microbiol 40: 3841-3844. PMID: 12354895
22. NCCLS (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-second edition.
23. Pasetto S, Pardi V, Murata RM (2014) Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model. PLoS One 9: e115323. doi: 10.1371/journal.pone.0115323 PMID: 25546350
24. Klepser ME, Wolfe EJ, Jones RN, Nightingale CH, Pfaller MA (1997) Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. Antimicrob Agents Chemother 41: 1392-1395. PMID: 9174207
25. Thein ZM, Samaranayake YH, Samaranayake LP (2007) Characteristics of dual species Candida biofilms on denture acrylic surfaces. Arch Oral Biol 52: 1200-1208. PMID: 17681271
26. Santana IL, Goncalves LM, de Vasconcellos AA, da Silva WJ, Cury JA, Del Bel Cury A (2013) Dietary carbohydrates modulate Candida albicans biofilm development on the denture surface. PLoS One 8: e64645. doi: 10.1371/journal.pone.0064645 PMID: 23737992
27. Alnuaimi AD, O'Brien-Simpson NM, Reynolds EC, McCullough MJ (2013) Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms. FEMS Yeast Res 13: 689-699. doi: 10.1111/1567-1364.12068 PMID: 23927631
28. Sumathy V, Zakaria Z, Jothy SL, Gothai S, Vijayarathna S, Yoga Latha L, et al. (2014) In vitro and in vivo antifungal activity of Cassia surattensis flower against Aspergillus niger. Microb Pathog 77: 7-12. doi: 10.1016/j.micpath.2014.10.004 PMID: 25457794
29. Pande M, Dubey VK, Yadav SC, Jagannadham MV (2006) A novel serine protease cryptolepain from Cryptolepis buchanani: purification and biochemical characterization. J Agric Food Chem 54: 10141-10150. PMID: 17177552
30. Goncalves LM, Del Bel Cury AA, Sartoratto A, Garcia Rehder VL, Silva WJ (2012) Effects of undecylenic acid released from denture liner on Candida biofilms. J Dent Res 91: 985-989. PMID: 22904206
31. Taniguchi L, de Fatima Faria B, Rosa RT, de Paula ECA, Gursky LC, Elifio Esposito SL, et al. (2009) Proposal of a low-cost protocol for colorimetric semi-quantification of secretory phospholipase by Candida albicans grown in planktonic and biofilm phases. J Microbiol Methods 78: 171-174. doi: 10.1016/j. mimet.2009.05.012 PMID: 19464327
32. Wong SS, Kao RY, Yuen KY, Wang Y, Yang D, Samaranayake LP, et al. (2014) In vitro and in vivo activity of a novel antifungal small molecule against Candida infections. PLoS One 9: e85836. doi: 10. 1371/journal.pone.0085836 PMID: 24465737
33. Yano J, Kolls JK, Happel KI, Wormley F, Wozniak KL, Fidel PL (2012) The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway. PLoS One 7: e46311. doi: 10.1371/journal.pone.0046311 PMID: 23050010
34. O'Brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267: 5421-5426. PMID: 10951200
35. Solis NV, Filler SG (2012) Mouse model of oropharyngeal candidiasis. Nat Protoc 7: 637-642. doi: 10. 1038/nprot.2012.011 PMID: 22402633
36. Ryder NS (1999) Antifungal agents. IDrugs 2: 1253-1255. PMID: 16113946
37. Neidrauer M, Ercan UK, Bhattacharyya A, Samuels J, Sedlak J, Trikha R, et al. (2014) Antimicrobial efficacy and wound-healing property of a topical ointment containing nitric-oxide-loaded zeolites. J Med Microbiol 63: 203-209. doi: 10.1099/jmm.0.067322-0 PMID: 24196133
38. Ohta K, Nishi H, Fukui A, Shigeishi H, Takechi M, Kamata N (2010) CX3CL1 expression induced by Candida albicans in oral fibroblasts. FEMS Immunol Med Microbiol 60: 179-185. doi: 10.1111/j.1574-695X.2010.00734.x PMID: 20880200
39. Shahzad M, Sherry L, Rajendran R, Edwards CA, Combet E, Ramage G, et al. (2014) Utilising polyphenols for the clinical management of Candida albicans biofilms. Int J Antimicrob Agents 44: 269-273. doi: 10.1016/j.ijantimicag.2014.05.017 PMID: 25104135
40. Messier C, Grenier D (2011) Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. Mycoses 54: e801-806. doi: 10.1111/j. 1439-0507.2011.02028.x PMID: 21615543
41. Gresnigt MS, Joosten LA, Verschueren I, van der Meer JW, Netea MG, Dinarello CA, et al. (2012) Neutrophil-mediated inhibition of proinflammatory cytokine responses. J Immunol 189: 4806-4815. doi: 10. 4049/jimmunol.1103551 PMID: 23053514
42. Lermann U, Morschhauser J (2008) Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology 154: 3281-3295. doi: 10.1099/mic.0.2008/ 022525-0 PMID: 18957582
43. Samaranayake YH, Dassanayake RS, Cheung BP, Jayatilake JA, Yeung KW, Yau JY, et al. (2006) Differential phospholipase gene expression by Candida albicans in artificial media and cultured human oral epithelium. Apmis 114: 857-866. PMID: 17207086
44. Theiss S, Ishdorj G, Brenot A, Kretschmar M, Lan CY, Nichterlein T, et al. (2006) Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulence. Int J Med Microbiol 296: 405-420. PMID: 16759910
45. Akpan A, Morgan R (2002) Oral candidiasis. Postgrad Med J 78: 455-459. PMID: 12185216